Jeremy Grantham Merck & Co., Inc. Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $29.8 Billion
- Q4 2024
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 6,165,271 shares of MRK stock, worth $552 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
6,165,271
Previous 5,912,044
4.28%
Holding current value
$552 Million
Previous $671 Million
8.65%
% of portfolio
2.06%
Previous 2.14%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,952Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.8 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.23 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.48 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $227B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...